HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcomes of neonatal screening for congenital hypothyroidism.

Abstract
The introduction of screening for congenital hypothyroidism has led to a marked improvement in neurodevelopmental outcome that has largely been attributed to the introduction of early treatment in the form of thyroxine. However, recent research has shown that the effect of hypothyroidism on the developing brain can result in specific developmental defects regardless of the early commencement of treatment. These defects consist predominantly of defective motor skills, clumsiness, learning difficulties, and behavior problems.
AuthorsM Dattani, C G Brook
JournalCurrent opinion in pediatrics (Curr Opin Pediatr) Vol. 8 Issue 4 Pg. 389-95 (Aug 1996) ISSN: 1040-8703 [Print] United States
PMID8954273 (Publication Type: Journal Article, Review)
Chemical References
  • Thyroxine
Topics
  • Child Development
  • Congenital Hypothyroidism
  • Humans
  • Hypothyroidism (diagnosis, drug therapy, psychology)
  • Infant, Newborn
  • Neonatal Screening
  • Thyroxine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: